032566784	032566784	CD	B-NP	O
|	|	NNP	I-NP	O
IMHNH	IMHNH	NNP	I-NP	O
|	|	VBD	B-VP	O
32147963	32147963	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1002973	1002973	CD	B-NP	O
|	|	CC	I-NP	O
1/1/2004	1/1/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
hereditary	hereditary	JJ	I-NP	O
angioedema	angioedema	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/22/2004	10/22/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/21/2004	6/21/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
RONNE	RONNE	NNP	B-NP	O
,	,	,	O	O
JEFF	JEFF	NNP	B-NP	O
L.	L.	NNP	I-NP	O
882-12-27-0	882-12-27-0	CD	I-NP	O
News	News	NNP	I-NP	O
Sa	Sa	NNP	I-NP	O
Rie	Rie	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
6/21/04	6/21/04	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SHAH	SHAH	NNP	B-NP	O
,	,	,	O	O
WAYNE	WAYNE	NNP	B-NP	O
W.	W.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
81	81	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
ATENOLOL	ATENOLOL	NN	I-NP	O
75	75	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
DANAZOL	DANAZOL	NN	I-NP	O
200	200	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
DIGOXIN	DIGOXIN	NN	I-NP	O
0.125	0.125	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QOD	QOD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/1/04	3/1/04	CD	B-NP	O
by	by	IN	B-PP	O
RZASA	RZASA	NN	B-NP	B-protein
,	,	,	O	O
JEFF	JEFF	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SYNTHROID	SYNTHROID	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
95304191	95304191	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DIGOXIN	DIGOXIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
DIGOXIN	DIGOXIN	NN	I-NP	O
0.187	0.187	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QOD	QOD	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
alternate	alternate	JJ	B-NP	O
digoxin	digoxin	NN	I-NP	O
doses	dose	VBZ	B-VP	O
Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/1/04	3/1/04	CD	B-NP	O
by	by	IN	B-PP	O
COUCHMAN	COUCHMAN	NN	B-NP	O
,	,	,	O	O
ROCKY	ROCKY	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SYNTHROID	SYNTHROID	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
95304191	95304191	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DIGOXIN	DIGOXIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
COLACE	COLACE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PEPCID	PEPCID	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FAMOTIDINE	FAMOTIDINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/1/04	3/1/04	CD	B-NP	O
by	by	IN	B-PP	O
CONFER	CONFER	NN	B-NP	O
,	,	,	O	O
NATHANIEL	NATHANIEL	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LASIX	LASIX	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
66305460	66305460	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Sulfa	Sulfa	NNP	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
RASH	RASH	NN	B-NP	B-protein
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
SYNTHROID	SYNTHROID	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/1/04	3/1/04	CD	B-NP	O
by	by	IN	B-PP	O
TAORMINA	TAORMINA	NN	B-NP	O
,	,	,	O	O
ARIEL	ARIEL	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DIGOXIN	DIGOXIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DIGOXIN	DIGOXIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	B-DNA
RHINOCORT	RHINOCORT	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
BUDESONIDE	BUDESONIDE	NNP	I-NP	I-DNA
NASAL	NASAL	NNP	I-NP	I-DNA
INHALER	INHALER	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
1	1	CD	I-NP	I-DNA
SPRAY	SPRAY	NN	I-NP	I-DNA
NA	NA	NN	I-NP	I-DNA
BID	BID	NN	I-NP	I-DNA
ALLEGRA	ALLEGRA	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
FEXOFENADINE	FEXOFENADINE	NN	I-NP	I-DNA
HCL	HCL	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
60	60	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BID	BID	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

ZANTAC	ZANTAC	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
RANITIDINE	RANITIDINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
150	150	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
Restrictions	Restriction	NNS	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Politz	Politz	NNP	I-NP	O
423-206-5279	423-206-5279	CD	I-NP	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
July	July	NNP	B-NP	O
,	,	,	O	O
9	9	CD	B-NP	O
:	:	SYM	O	O
15	15	CD	B-NP	O
am	am	NN	I-NP	O
-	-	HYPH	I-NP	O
Xand	Xand	NN	I-NP	B-protein
A	A	NN	I-NP	I-protein
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
IV	IV	CD	B-NP	O
Contrast	Contrast	NN	I-NP	O
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
QUINIDINE	QUINIDINE	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
,	,	,	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
,	,	,	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
,	,	,	O	O
NITROFURANTOIN	NITROFURANTOIN	NN	B-NP	B-protein
,	,	,	O	O
STANAZOL	STANAZOL	NN	B-NP	O
,	,	,	O	O
PROCAINE	PROCAINE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
,	,	,	O	O
Dairy	Dairy	NNP	B-NP	O
Products	Products	NNP	I-NP	O
,	,	,	O	O
WHEAT/GLUTEN	WHEAT/GLUTEN	NNP	B-NP	O
,	,	,	O	O
NITROFURANTOIN	NITROFURANTOIN	NNP	B-NP	O
MACROCRYSTAL	MACROCRYSTAL	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
hereditary	hereditary	JJ	B-NP	O
angioedema	angioedema	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
hereditary	hereditary	JJ	I-NP	O
angioedema	angioedema	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HEREDITARY	HEREDITARY	NNP	I-NP	O
ANGIOEDEMA	ANGIOEDEMA	NNP	I-NP	O
AFIB	AFIB	NNP	I-NP	O
-	-	HYPH	B-NP	O
lodose	lodose	JJ	I-NP	O
Coum/ASA	Coum/ASA	NN	I-NP	O
HYPOTHY	HYPOTHY	NN	I-NP	O
H/O	H/O	NN	I-NP	O
SUBDURAL	SUBDURAL	NN	I-NP	O
ON	ON	NN	I-NP	O
COUM	COUM	NN	I-NP	O
S/P	S/P	NN	I-NP	O
APPY	APPY	NN	I-NP	O
,	,	,	O	O
TAH	TAH	NN	B-NP	B-protein
tracheostomies	tracheostomy	NNS	I-NP	I-protein
x	x	SYM	O	I-protein
3	3	CD	B-NP	I-protein
multiple	multiple	JJ	I-NP	O
intubations	intubation	NNS	I-NP	O
DVT	DVT	NN	I-NP	O
,	,	,	O	O
ivc	ivc	NN	B-NP	O
filter	filter	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
GERD	GERD	NN	I-NP	O
polycythemia	polycythemia	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
82	82	CD	B-NP	O
y.o.	y.o.	NN	I-NP	O
femalew	femalew	VBD	B-VP	O
tih	tih	NN	B-NP	O
long	long	JJ	I-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
hereditary	hereditary	JJ	B-NP	O
angioedema	angioedema	NN	I-NP	O
-	-	HYPH	B-NP	O
s/p	s/p	NN	I-NP	O
multiple	multiple	JJ	I-NP	O
remote	remote	JJ	I-NP	O
prior	prior	JJ	I-NP	O
tracheostomies	tracheostomy	NNS	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
airway	airway	NN	B-NP	O
edema	edema	NN	I-NP	O
-	-	HYPH	B-VP	O
now	now	RB	I-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
lip	lip	NN	B-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
recent	recent	JJ	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
GI	GI	NN	B-NP	O
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
-	-	HYPH	B-ADVP	O
with	with	IN	B-PP	O
bowel	bowel	NN	B-NP	O
swelling	swelling	NN	I-NP	O
/	/	SYM	B-NP	O
N/V/abdominal	N/V/abdominal	JJ	I-NP	B-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

Has	Ha	NNS	B-NP	B-protein
been	be	VBN	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
stanazol	stanazol	NN	B-NP	O
previously	previously	RB	B-ADVP	O
,	,	,	B-PP	O
but	but	CC	I-PP	O
on	on	IN	B-PP	O
danazol	danazol	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
several	several	JJ	I-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
admission	admission	NN	I-NP	O
for	for	IN	B-PP	O
LGIB	LGIB	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
outpatient	outpatient	NN	I-NP	O
elective	elective	JJ	I-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
ultimately	ultimately	RB	B-ADVP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
stricture	stricture	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
dilated	dilate	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
persistent	persistent	JJ	B-NP	O
GI	GI	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
angioedema	angioedema	NN	I-NP	O
attack	attack	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
danazol	danazol	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
200	200	CD	B-NP	O
bid	bid	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
midst	midst	NN	I-NP	O
of	of	IN	B-PP	O
tapering	taper	VBG	B-VP	O
this	this	DT	B-NP	O
medication	medication	NN	I-NP	O
down	down	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
Allergist	Allergist	NNP	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Petite	Petite	NNP	I-NP	O
,	,	,	O	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
now	now	RB	I-VP	O
developed	develop	VBN	I-VP	O
upper	upper	JJ	B-NP	O
lip	lip	NN	I-NP	O
swelling	swell	VBG	B-VP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
-	-	HYPH	O	O
which	which	WDT	B-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
worsening	worsen	VBG	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
.	.	.	O	O

PMHx	PMHx	NN	B-NP	O
:	:	:	O	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
colonic	colonic	JJ	B-NP	O
strictures	stricture	NNS	I-NP	O
,	,	,	O	O
DVT	DVT	NN	B-NP	O
s/p	s/p	NN	I-NP	O
IVC	IVC	NN	I-NP	O
filter	filter	NN	I-NP	O
,	,	,	O	O
?	?	.	O	O

DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
afib	afib	NN	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
MI	MI	NN	I-NP	I-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	O
sigmoid	sigmoid	JJ	I-NP	O
colostomy	colostomy	NN	I-NP	O
.	.	.	O	O

Long	Long	JJ	B-NP	O
list	list	NN	I-NP	O
of	of	IN	B-PP	O
allergies	allergy	NNS	B-NP	O
including	include	VBG	B-PP	O
IV	IV	CD	B-NP	O
contrast	contrast	NN	I-NP	O
,	,	,	O	O
PCN	PCN	NN	B-NP	B-protein
,	,	,	O	O
levaquin	levaquin	NN	B-NP	O
.	.	.	O	O

Meds	Med	NNS	B-NP	O
include	include	VBP	B-VP	O
danazole	danazole	NN	B-NP	O
100	100	CD	I-NP	O
QD	QD	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
exam	exam	NN	B-NP	O
,	,	,	O	O
-	-	HYPH	B-NP	O
afebrile	afebrile	JJ	B-ADJP	O
,	,	,	O	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
ra	ra	NN	I-NP	O
,	,	,	O	O
bp	bp	NN	B-NP	O
105/80	105/80	CD	I-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
80s	80	NNS	I-NP	O
.	.	.	O	O

sitting	sit	VBG	B-VP	O
up	up	RP	B-PRT	O
comfortably	comfortably	RB	B-ADVP	O
,	,	,	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
speak	speak	VB	I-VP	O
with	with	IN	B-PP	O
slightly	slightly	RB	B-NP	O
muddled	muddled	JJ	I-NP	O
pronouncitation	pronouncitation	NN	I-NP	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
upper	upper	JJ	I-NP	O
lip	lip	NN	I-NP	O
swelling	swell	VBG	B-VP	O
to	to	TO	B-PP	O
twice	twice	JJ	B-NP	O
size	size	NN	I-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
right	right	JJ	I-NP	O
side	side	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
uvula	uvula	NN	I-NP	O
swelling	swelling	NN	I-NP	O
noted	note	VBD	B-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
stridor	stridor	NN	I-NP	O
or	or	CC	O	O
increased	increase	VBN	B-NP	O
secreations	secreation	NNS	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Irregular	Irregular	JJ	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
with	with	IN	B-PP	O
3/6	3/6	CD	B-NP	O
HSM	HSM	NN	I-NP	O
at	at	IN	B-PP	O
LLSB	LLSB	NNP	B-NP	B-protein
.	.	.	O	O

Faint	Faint	NN	B-NP	O
crackles	crackle	NNS	I-NP	O
at	at	IN	B-PP	O
bases	base	NNS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
rashes	rash	NNS	I-NP	O
noted	note	VBD	B-VP	O
.	.	.	O	O

Labs	Lab	NNS	B-NP	O
remarkable	remarkable	JJ	B-ADJP	O
only	only	RB	B-ADVP	O
for	for	IN	B-PP	O
Cr	Cr	NN	B-NP	B-protein
1.2	1.2	CD	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
basline	basline	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
CBC	CBC	NN	I-NP	O
,	,	,	O	O
Normal	Normal	JJ	B-NP	O
coags	coag	NNS	I-NP	O
.	.	.	O	O

C1Q/c4/c2	C1Q/c4/c2	NN	B-NP	B-protein
/	/	SYM	I-NP	O
c1	c1	NN	I-NP	B-protein
esterase	esterase	NN	I-NP	I-protein
inhibitor	inhibitor	NN	I-NP	O
results	result	VBZ	B-VP	O
all	all	DT	B-NP	O
pending	pende	VBG	I-NP	O
.	.	.	O	O

Impression/Hospital	Impression/Hospital	NN	B-NP	O
course	course	NN	I-NP	O
:	:	:	O	O
82	82	CD	B-NP	O
y.o.	y.o.	NN	I-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
heriditary	heriditary	JJ	B-NP	O
angioedema	angioedema	NN	I-NP	O
,	,	,	O	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
lip	lip	NN	B-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
CCU	CCU	NN	B-NP	B-protein
for	for	IN	B-PP	O
observation	observation	NN	B-NP	O
in	in	IN	B-PP	O
case	case	NN	B-NP	O
of	of	IN	B-PP	O
airway	airway	NN	B-NP	O
instability	instability	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
higher	high	JJR	B-NP	O
dose	dose	NN	I-NP	B-protein
danazol	danazol	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
200	200	CD	I-NP	I-protein
tid	tid	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
FFP	FFP	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
premedicated	premedicate	VBN	I-VP	O
with	with	IN	B-PP	O
benadryl	benadryl	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

FFP	FFP	NN	B-NP	B-protein
replaces	replace	VBZ	B-VP	O
C1	C1	NN	B-NP	B-protein
esterase	esterase	NN	I-NP	I-protein
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
required	require	VBD	B-VP	O
single	single	JJ	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
lasix	lasix	NN	I-NP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
I/O	I/O	NN	B-NP	O
status	status	NN	I-NP	O
during	during	IN	B-PP	O
FFP	FFP	NN	B-NP	O
infusion	infusion	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
rapid	rapid	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
over	over	IN	B-PP	O
24-48	24-48	CD	B-NP	O
hours	hour	NNS	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
airway	airway	NN	B-NP	O
compromise	compromise	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
closely	closely	RB	B-ADVP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
allergist	allergist	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
leave	leave	VB	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
danazol	danazol	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
some	some	DT	B-NP	O
consideration	consideration	NN	I-NP	O
of	of	IN	B-PP	O
re-instituting	re-instituting	JJ	B-NP	O
stanazol	stanazol	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
f/u	f/u	NN	B-NP	O
with	with	IN	B-PP	O
allergist	allergist	NN	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Wakeford	Wakeford	NNP	I-NP	O
in	in	IN	B-PP	O
5	5	CD	B-NP	O
days	day	NNS	I-NP	O
f/u	f/u	NN	I-NP	O
complement	complement	NN	I-NP	O
panel	panel	NN	I-NP	O
studies	study	NNS	I-NP	O
ADDITIONAL	ADDITIONAL	VBP	B-VP	O
COMMENTS	COMMENTS	NNS	B-NP	O
:	:	:	O	O
return	return	VB	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
notice	notice	VBP	B-VP	O
any	any	DT	B-NP	O
lip	lip	NN	I-NP	O
swelling	swelling	NN	I-NP	O
or	or	CC	I-NP	O
difficulty	difficulty	NN	I-NP	O
breathing	breathing	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
OVERGAARD	OVERGAARD	NNP	B-NP	O
,	,	,	O	O
KIP	KIP	NNP	B-NP	O
G.	G.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.S.	M.S.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
QL28	QL28	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6/21/04	6/21/04	CD	I-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
01	01	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

